A database of FDA approved therapeutic peptides and proteins
| ID | ThPPID | Name | Peptide Sequence | Length | Functional Classification | Disease | Brand | Company | Physical Appearance | Route of Administartion | Category | Target |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1726 | Th1175 | Desirudin | NA Full view | 0 | Ib | Hematological Disorders | Iprivask | Valeant Pharmaceuticals North America LLC | NA | Subcutaneous | NA | NA |
| 1727 | Th1175 | Desirudin | NA Full view | 0 | Ib | Hematological Disorders | Iprivask | Marathon Pharmaceuticals, LLC | NA | NA | NA | NA |
| 1745 | Th1180 | Fibrinogen Concentrate (Human) | NA Full view | 0 | Ia | Genetic/Hematological | Riastap | Csl Behring Gmb H | Injection, Powder, Lyophilized, for Solution | Intravenous | NA | NA |
| 1746 | Th1180 | Fibrinogen Concentrate (Human) | NA Full view | 0 | Ia | Genetic/Hematological | Artiss Frozen | Baxter Healthcare Corporation | NA | NA | NA | NA |
| 1747 | Th1180 | Fibrinogen Concentrate (Human) | NA Full view | 0 | Ia | Genetic/Hematological | Evicel Fibrin Sealant (human) | Ethicon Inc | NA | NA | NA | NA |
| 1748 | Th1180 | Fibrinogen Concentrate (Human) | NA Full view | 0 | Ia | Genetic/Hematological | Raplixa | Pro Fibrix Bv | NA | NA | NA | NA |
| 1749 | Th1180 | Fibrinogen Concentrate (Human) | NA Full view | 0 | Ia | Genetic/Hematological | Tachosil | Baxter Healthcare Corporation | NA | NA | NA | NA |
| 1750 | Th1180 | Fibrinogen Concentrate (Human) | NA Full view | 0 | Ia | Genetic/Hematological | Tisseel | Baxter Healthcare Corporation | NA | NA | NA | NA |
| 1751 | Th1180 | Fibrinogen Concentrate (Human) | NA Full view | 0 | Ia | Genetic/Hematological | Tisseel Frozen | Baxter Healthcare Corporation | NA | NA | NA | NA |
| 1782 | Th1189 | Idarucizumab | NA Full view | 0 | Ib | Hematological Disorders | Praxbind | Boehringer Ingelheim Pharmaceuticals, Inc. | Injection | Intravenous | Anticoagulant | NA |
| 1799 | Th1193 | Turoctocog alfa | NA Full view | 0 | Ia | Hematological Disorders | Zonovate | Novo Nordisk Canada Inc | sterile, non-pyrogenic, white or slightly yellow Powder | Intravenous | NA | NA |
| 1801 | Th1195 | Simoctocog Alfa | NA Full view | 0 | Ia | Hematological Disorders | Nuwiq | Octapharma Pharmazeutika Produktionsges M B H | Powder and solvent for Solution | Intravenous infusion | Antihaemorrhagics: blood coagulation factor VIII | NA |
| 1806 | Th1200 | Prothrombin complex concentrate | NA Full view | 0 | Ia | Hematological Disorders | Feiba Nf | Baxter Healthcare Corporation | Freeze-dried fraction | Intravenous | NA | NA |
| 1807 | Th1200 | Prothrombin complex concentrate | NA Full view | 0 | Ia | Hematological Disorders | Cofact | Sanquin | NA | Intravenous | NA | NA |
| 1808 | Th1200 | Prothrombin complex concentrate | NA Full view | 0 | Ia | Hematological Disorders | Kcentra | Csl Behring Ag | Nanofiltered and Lyophilized non-activated four-factor Prothrombin Complex Concentrate | Intravenous | NA | NA |
| 1809 | Th1200 | Prothrombin complex concentrate | NA Full view | 0 | Ia | Hematological Disorders | Octaplex | Octapharma | Powder and solvent for Solution | Intravenous | NA | NA |
| 1818 | Th1209 | Methoxy polyethylene glycol-epoetin beta | NA Full view | 0 | Ib | Hematological Disorders | Mircera | Genentech, Inc. | Solution for Injection | Intravenous | NA | |
| 1827 | Th1217 | Anti-inhibitor coagulant complex | NA Full view | 0 | Ia | Hematological Disorders | Feiba Nf | NA | Solid | Intravenous | Blood Coagulation Factors, Antihemophilic Agent | NA |
| 1836 | Th1225 | Coagulation factor X human | NA Full view | 0 | Ib | Hematological Disorders | Coagadex | NA | powder and solvent used to make a solution | Intravenous | Blood Coagulation Factors | NA |
| 1838 | Th1227 | Efmoroctocog alfa | NA Full view | 0 | Ib | Hematological Disorders | ELOCTA | NA | Powder and solvent for solution for injection | Intravenous | Antihemophilic Factor | NA |
| 1839 | Th1228 | Factor IX Complex (Human) | NA Full view | 0 | Ib | Hematological Disorders | AlphaNine SD or Mononine | Powder and solvent for solution for injection | Intravenous | Antihemophilic agent | NA | |
| 1846 | Th1234 | Protamine sulfate | NA Full view | 0 | Ib | Hematological Disorders | Protamine Sulfate Injection, USP | Omega Laboratories Ltd | off-white amorphous or crystalline powder | Intravenous | Heparin Antagonists, Hematologic Agents | NA |
| 1851 | Th1238 | Susoctocog alfa | AIRRYYLGAVELSWDYRQSE Full view | 1448 | Ib | Hematological Disorders | Obizur | NA | Powder and solvent for solution for injection. | Intravenous | Blood coagulation factors, Antihaemorrhagics | von Willebrand factor |
| 1852 | Th1239 | Thrombomodulin Alfa | NA Full view | 0 | Ib | Hematological Disorders | Recomodulin (in Japan only) | Asahi Kasei Pharma Corp | lyophilized powder for solution | Intravenous | Anticoagulant agent, Antiplatelet agent | Prothrombin, Coagulation factor V |